Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer

Postgraduate Medical Journal - Tập 78 Số 916 - Trang 92-93 - 2002
L. Vini1, Stephen Hyer1, Amal Al-Saadi1, B. Pratt1, Clive Harmer1
1Thyroid Unit, Royal Marsden NHS Trust , Sutton, Surrey , UK

Tóm tắt

Abstract The aim of this study was to review the outcome of ablative radioiodine treatment on ovarian function in young women treated for differentiated thyroid carcinoma. Of 1398 patients with differentiated thyroid cancer, 496 were women under the age of 40 at the time of diagnosis who had received radioiodine therapy. Of these, 322 received a single 3 GBq ablation dose of radioiodine while the remainder received subsequent treatment with 131I with a cumulative activity of 8.5–59 GBq for residual, recurrent, or metastatic disease. Transient amenorrhoea or menstrual irregularities lasting up to 10 months were experienced in 83 patients (17%). No cases of permanent ovarian failure were recorded. There were 427 children born to 276 women; only one patient wishing to achieve a successful pregnancy outcome has been unsuccessful. Four premature births and 14 miscarriages occurred but no congenital abnormalities were reported. The risk of permanent damage to the ovaries after ablative radioiodine treatment appears to be low and patients can be reassured they can have normal pregnancies after this treatment.

Từ khóa


Tài liệu tham khảo

Raymond, 1989, Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine, J Clin Endocrin Metab, 69, 186, 10.1210/jcem-69-1-186

Dottorini, 1995, Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma, J Nucl Med, 36, 21

Schlumberger, 1996, Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients, J Nucl Med, 37, 606

Harmer, 1996, Thyroid cancer: differentiated carcinoma, Cancer Treat Rev, 22, 161, 10.1016/S0305-7372(96)90001-8

Vini, 2000, Radioiodine treatment for differentiated thyroid cancer, Clin Oncol, 12, 365, 10.1053/clon.2000.9196

1975, Medical internal radiation dose. Dose estimate report No 5, J Nucl Med, 16, 857

Izembart, 1992, Retrospective evaluation of the dose received by the ovary after iodine therapy for thyroid cancer, Eur J Nucl Med, 19, 243, 10.1007/BF00175136

Vini, 1998, In vivo dosimetry of radioiodine in patients with metastatic differentiated thyroid cancer, Eur J Nucl Med, 25, 904

Thông tin
Thông tin xuất bản

Postgraduate Medical Journal

Tập 78 Số 916

92-93

Thông tin tác giả